Autres langues Xvivo Perfusion AB

Actions

XVIVO

SE0004840718

Marché Fermé - Nasdaq Stockholm Autres places de cotation 17:29:51 25/04/2024			Varia. 5j.	Varia. 1 janv.
356,5 ^SEK	-3,26 %		+11,06 %	+8,19 %

08:47	AVIS D'ANALYSTES DU JOUR : Kering, Carrefour, STMicroelectronics, ArgenX, Ipsen, Accor, Moncler...
24/04	Transcript : Xvivo Perfusion AB, Q1 2024 Earnings Call, Apr 24, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)	15:40
LE OPINIONI DEGLI ANALISTI DEL GIORNO : Moncler, Boreo, Fugro, STMicroelectronics, Alfen, Iberdrola, Roche, Temenos, Akzo Nobel...	09:00
OPINIONES DE LOS ANALISTAS DEL DÍA : Aedas Homes, Almirall, STMicroelectronics, Enagás, Iberdrola, Roche, Temenos, Moncler...	08:00
Nordic Shares Declined Wednesday; Svenska Handelsbnkn Ser A Fell Furthest	24/04
Xvivo Perfusion AB Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04
Estimates compiled by Modular Finance on behalf of XVIVO Perfusion.	19/04
Xvivo Perfusion : Results from XVIVO's clinical trial NIHP2019 for heart preservation presented at ISHLT in Prague	11/04
Results from XVIVO’s clinical trial NIHP2019 for heart preservation presented at ISHLT in Prague	11/04
Xvivo Perfusion AB Announces Results from Clinical Trial NIHP2019 for Heart Preservation Presented at ISHLT in Prague	11/04
Xvivo Perfusion : Notice to AGM 2024	21/03
Xvivo Perfusion : SORP 2024	21/03
Xvivo Perfusion : Styrelsens 19-22 redogörelse (Eng)	21/03
NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN XVIVO PERFUSION AB (PUBL)	21/03
Certain Shares of Xvivo Perfusion AB are subject to a Lock-Up Agreement Ending on 16-MAR-2024.	16/03
The first-ever transplantation with a donor heart transported across the Atlantic Ocean – made possible by the use of XVIVO’s heart technology	29/02
Nordic Shares Moved Upward Thursday; Nokia Topped Leaders	25/01
XVIVO presents Report on Operations 2023	25/01
Xvivo Perfusion AB Reports Earnings Results for the Full Year Ended December 31, 2023	25/01
Xvivo Perfusion AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	25/01
Nordic Stocks Decreased Wednesday; Kone B Posted Biggest Loss	17/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Xvivo Perfusion AB

Actions

XVIVO

SE0004840718

Autres langues

Filtres